Qol Medical Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Qol Medical

Access the complete profile.

Qol Medical Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	3405 Ocean Dr Vero Beach, FL 32963

Note: Revenues for privately held companies are statistical evaluations.


Qol Medical's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Qol Medical's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Qol Medical is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Qol Medical Annual Revenue and Growth Rate

Qol Medical	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Qol Medical's revenues are gauged from an analysis of company filings.

Qol Medical's Income Statement (based on Industry Averages)

Qol Medical P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Qol Medical is developing and marketing. Qol Medical doesn't have any recent trademark applications, indicating Qol Medical is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
O Pharmaceutical preparations for the treatment or management of metabolic diseases, gastrointestinal diseases, vitamin or mineral deficiencies, and rare diseases, namely, orphan diseases	08/09/2018
ONE THERAPEUTICS Pharmaceutical preparations for the treatment or management of metabolic diseases, gastrointestinal diseases, vitamin or mineral deficiencies, and rare diseases, namely, orphan diseases	08/09/2018
CSIDCARES providing health information in the field of congenital sucrose-isomaltase deficiency and sucrose intolerance awareness, diagnosis and information about screening and treatment	09/21/2016

See all trademarks and details in the Full Report.

Market Share of Qol Medical's Largest Competitors

A competitive analysis shows these companies are in the same general field as Qol Medical, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Qol Medical. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
QOL MEDICAL	Vero Beach, FL	100
FAR RESEARCH INC. DBA FAR CHEMICAL	Palm Bay, FL	69
CROSS BRANDS CONTRACT FILLING	Rockledge, FL	36
ROCKLEDGE PHARMACEUTICAL MANUF	Rockledge, FL	23

Future Competition: Qol Medical's Fastest Growing Competitors

These companies are in the same general field as Qol Medical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)